Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

MOG-encoding DNA vaccines ameliorate EAE and display neuroprotective effects in treated mice summary


ABSTRACT: Vaccination with naked DNA encoding myelin basic protein represents a promising therapeutic strategy in multiple sclerosis (MS). In this study, we assessed the potential of vaccination with a DNA construct coding for the myelin oligodendrocyte glycoprotein (MOG), an important candidate autoantigen in MS, to induce tolerance and protect against experimental autoimmune encephalomyelitis (EAE). Herein, we demonstrated that MOG-DNA vaccination reduced the clinical and histopathological signs of EAE when administered in both prophylactic and therapeutic settings. Further mechanistic experiments revealed that the protective effects of MOG-DNA vaccines were associated with a reduction of antigen-specific Th1 and Th17 cellular immune responses and expansion of regulatory T cells in periphery, and up-regulation in the central nervous system of genes encoding neurotrophic factors and proteins involved in remyelination. These results may set the rationale for the use of MOG-based DNA vaccines to induce tolerance in MS patients. We analyzed brain and spinal cord samples from five treated and five control mice

ORGANISM(S): Mus musculus

SUBMITTER: Ramil Nurtdinov 

PROVIDER: E-GEOD-30482 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2011-07-08 | GSE30482 | GEO
2009-11-01 | E-MEXP-2237 | biostudies-arrayexpress
2010-12-31 | E-MEXP-2703 | biostudies-arrayexpress
2024-02-27 | GSE240800 | GEO
2024-02-27 | GSE240801 | GEO
2013-08-10 | E-MTAB-784 | biostudies-arrayexpress
2023-11-01 | GSE181506 | GEO
2019-08-08 | GSE130975 | GEO
2023-11-01 | GSE181526 | GEO
2024-05-14 | GSE267422 | GEO